EU regulator backs revoking Amgen's right to sell rare-disease drug - Reuters
EU regulator backs revoking Amgen's right to sell rare-disease drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxPQW1xek5kR0ljZzlCOUtEVnNfSWhSb2hVSVIxcTVGaWpoVllvaFF6VVhlNlRFNWtLWFFTc3lmcXpqZXZDOFk5UXFOZTdrTEdXS2diS0w0T21XWC1ZeVd1SUx2dXhTRU5HR1JGQUY3VTdKZlM5R2lzRFVDUl9KTVhmclRFSTV3aVU4MHBTd1BLZFRlM3NneUJkQTZXXzFmdm5rZFpfZmhUUkxpTWNiLVhOSVg5SkVqZ1RQSmNZSWY5YTI2TW5sX3NxOFk1bTU5TlpjZXhrUFI2TzRWZ2hE?oc=5" target="_blank">EU regulator backs revoking Amgen's right to sell rare-disease drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMUS FDA approves Takeda, Protagonist's drug for rare blood cancer - Reuters
US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters
August 28, 2026 at 10:16 PMUS FDA approves Roivant-Priovant's skin and muscle disease drug - Reuters
US FDA approves Roivant-Priovant's skin and muscle disease drug Reuters
August 27, 2026 at 10:42 PMAstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial - Reuters
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial Reuters
August 27, 2026 at 06:10 AMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AM